Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
| ▸ | CTSS | P25774 | 2/20 | 0.36 |
| ▸ | CTSK | P43235 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | GABRA2 | P47869 | 4/20 | 0.35 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.35 |
| ▸ | DPP4 | P27487 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | PDE2A | O00408 | 1/20 | 0.33 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.32 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.32 |
| ▸ | IDO1 | P14902 | 2/20 | 0.32 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.31 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | ICMT | O60725 | 1/20 | 0.30 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.30 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butylamine SCHEMBL6047452 | 0.82 | MEN1 (0.39) | CYP3A4MAPK1TSHRPDE2ADNM1 | |
| Tetrapentylammonium SCHEMBL527645 | 0.81 | SLC22A1 (0.41) | CYP3A4MAPK1MAPTGABRA2GABRB2 | |
| Tetrabuthylammonium SCHEMBL16668627 | 0.81 | SLC22A1 (0.41) | CYP3A4MAPK1CTSSCTSKMAPT | |
| SCHEMBL134606 | 0.81 | CYP3A4 (0.35) | CYP3A4MAPK1CTSSCTSKMAPT | |
| SCHEMBL31749536 | 0.79 | SLC22A1 (0.43) | CYP3A4MAPK1MAPTGABRA2GABRB2 | |
| SCHEMBL16669245 | 0.79 | SLC22A1 (0.43) | CYP3A4MAPK1MAPTGABRA2GABRB2 | |
| SCHEMBL4459420 | 0.79 | GABRA2 (0.35) | CYP3A4MAPK1CTSSCTSKMAPT | |
| SCHEMBL6288802 | 0.78 | CYP3A4 (0.34) | CYP3A4MAPK1CTSSCTSKMAPT | |
| SCHEMBL41567 | 0.78 | CES2 (0.44) | CYP3A4MAPK1MAPTTSHRTDP1 | |
| SCHEMBL15538611 | 0.77 | GABRA2 (0.36) | CYP3A4MAPK1MAPTGABRA2GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11760814-B2 | 1,5 diazabicyclooctane ligand systems and methods therewith | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2023-09-19 | — | — | US | disclosed |
| US-20210284763-A1 | 1,5 Diazabicyclooctane Ligand Systems and Methods Therewith | EXXONMOBIL CHEMICAL PATENTS INC. | 2021-09-16 | — | — | US | disclosed |
| EP-2006071-B1 | PROCESS FOR PRODUCING SHAPED ARTICLE BY T-DIE MOLDING | MITSUI CHEMICALS INC (JP) | 2012-02-22 | — | — | EP | disclosed |
| EP-2077283-B1 | ETHYLENE COPOLYMER, COMPOSITION CONTAINING THE COPOLYMER, AND USE OF THE SAME | MITSUI CHEMICALS INC (JP) | 2011-09-21 | — | — | EP | disclosed |
| EP-2006071-A9 | PROCESS FOR PRODUCING SHAPED ARTICLE BY T-DIE MOLDING | Mitsui Chemicals, Inc. (JP) | 2009-07-22 | — | — | EP | disclosed |
| EP-2006071-A2 | PROCESS FOR PRODUCING SHAPED ARTICLE BY T-DIE MOLDING | Mitsui Chemicals, Inc. (JP) | 2008-12-24 | — | — | EP | disclosed |
| EP-1640385-A2 | Process for preparing low molecular weight olefin (co)polymer and polymerizing catalyst used therefor | MITSUI CHEMICALS, INC. (JP) | 2006-03-29 | — | — | EP | disclosed |
| EP-1416000-A1 | Process for preparing low molecular weight olefin (co)polymer and polymerizing catalyst used therefor | Mitsui Chemicals, Inc. (JP) | 2004-05-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11760814-B2 | 1,5 diazabicyclooctane ligand systems and methods therewith | ODC1, DDT, OXGR1 | CYP3A4 803/4885MAPK1 2002/4885CTSS 1934/4885 |
| US-20210284763-A1 | 1,5 Diazabicyclooctane Ligand Systems and Methods Therewith | ODC1, DDT, OXGR1 | CYP3A4 803/4885MAPK1 2002/4885CTSS 1934/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.